Centaurus Financial, Inc. West Pharmaceutical Services Inc Transaction History

Centaurus Financial, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	SELL	$318.29 - $392.21 $105,035 - $129,429	-330 Reduced 52.8%	295 $103,000
Q2 2023 Aug 15, 2023	SELL	$334.63 - $382.47 $7,361 - $8,414	-22 Reduced 3.4%	625 $239,000
Q1 2023 May 17, 2023	BUY	$232.5 - $346.47 $5,115 - $7,622	22 Added 3.52%	647 $224,000
Q4 2022 Feb 10, 2023	BUY	$209.34 - $261.61 $130,837 - $163,506	625 New	625 $147,000
Q2 2022 Aug 02, 2022	SELL	$280.61 - $420.45 $3,086 - $4,624	-11 Reduced 2.7%	397 $120,000
Q1 2022 May 13, 2022	BUY	$357.49 - $445.92 $58,270 - $72,684	163 Added 66.53%	408 $168,000
Q4 2021 Feb 01, 2022	BUY	$402.25 - $471.34 $98,551 - $115,478	245 New	245 $115,000

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.